These studies decipher the pathways linking the formation of intracellular uromodulin aggregates, unfolded protein response and kidney damage in ADTKD, with relevance for therapeutic strategies and for toxic gain‐of‐function mechanisms in autosomal dominant diseases. This evidence concerns the gene UMOD and autosomal dominant medullary cystic kidney disease with or without hyperuricemia.